BEVACIZUMAB
Clinical trials for BEVACIZUMAB explained in plain language.
Never miss a new study
Get alerted when new BEVACIZUMAB trials appear
Sign up with your email to follow new studies for BEVACIZUMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to shrink brain tumors while saving memory
Disease control Recruiting nowThis study tests two ways to treat lung cancer that has spread to the brain. One group gets focused radiation plus a drug called bevacizumab; the other gets whole-brain radiation that tries to protect the memory center. The goal is to see which approach better controls the brain …
Matched conditions: BEVACIZUMAB
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 26, 2026 10:12 UTC
-
New hope for tough liver cancer: combo therapy targets tumors with vein clots
Disease control Recruiting nowThis study tests a combination of two immunotherapy drugs (iparomlimab and tuvonralimab, together called QL1706), a targeted therapy (bevacizumab), and chemotherapy given directly into the liver artery for people with advanced liver cancer that has spread into the main portal vei…
Matched conditions: BEVACIZUMAB
Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated May 22, 2026 14:03 UTC